Title : Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.

Pub. Date : 1999 Dec

PMID : 10591680






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared with placebo, both raloxifene and CEEs lowered the level of low density lipoprotein cholesterol by 0.53 to 0.79 mmol/L (all P<0.04) and lowered, at 24 months, the level of fibrinogen by 0.71 to 0.86 g/L (all P<0.05). Raloxifene Hydrochloride fibrinogen beta chain Homo sapiens
2 Our findings suggest that in healthy postmenopausal women, raloxifene and estrogen monotherapy have similar beneficial effects on low density lipoprotein cholesterol and fibrinogen levels. Raloxifene Hydrochloride fibrinogen beta chain Homo sapiens